SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Here’s how AI helped CrazyLabs achieve 7 billion downloads

"Israel is well-positioned to not only participate in the global AI arms race but also to define its trajectory"

Israel inks multi-billion-shekel deal to replenish Arrow 3 stocks

Gigi Levy-Weiss: “Funds that used to visit Israel every month haven’t been here for a year and a half”

Buzz

Most popular

Daily

Weekly

1

Have missiles from the Iranian-backed Houthis discovered a loophole in Israeli air defenses?

2

Windward acquired for $270M by FTV Capital, doubling its IPO valuation

3

$41B in exits: Why Israeli cyber startups are a global powerhouse

4

Coralogix acquires Aporia in $50M deal to boost AI system transparency

5

Kaltura CEO: "Just like a missile hit our office, a missile hit us with the IPO"

Pharmaceuticals

20 stories about Pharmaceuticals

קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich

Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price

נאסד"ק וול סטריט

Liver Treatment Company Galmed Looking to Raise $75 Million in Public Offering

20.06.18|Dror Reich

Galmed listed on Nasdaq in 2014. The company's stock jumped around 125% over the past two weeks following a successful study

MediWound’s Pineapple-Based Burn Treatment to Treat Mustard Gas Burns

31.05.18|Dror Reich

The Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries

Ferring Per Falk

At Swiss Pharma Company, Women’s Health Gets Personal

23.05.18|Lilach Baumer

Ferring Pharmaceuticals recently launched a personalized fertility treatment that supports its hormone therapy with a dosage calculation app

וורן באפט אסיפת בעלי המניות מאי 2018

Berkshire Hathaway Solidified its Teva Position in 2018 First Quarter

16.05.18|Lilach Baumer

According to a Tuesday filing, Berkshire Hathaway more than doubled its Teva stake during the first quarter of 2018

בריאות דיגיטלית מדעי החיים רפואה טיפול 1

Israel’s Life Sciences Industry Is Dominated by Small Scale Startups

14.05.18|Lilach Baumer

65% of all Israel-based life sciences companies employ 10 people or less, according to a new report

מטה טבע פתח תקווה

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich

The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman

Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April

מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

Three Board Members to Leave Distraught Drugmaker Teva

26.04.18|Lilach Baumer and Dror Reich

Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years

מנכ"ל ג'נרל אלקטריק ג'ון פלאנרו

General Electric, Roche Weigh Israel, Finland as Possible Locations for Joint Research Operation

22.04.18|Yoav Stoler

The World Economic Forum’s global competitiveness report for 2017-2018 ranked Israel third in innovation and Finland fourth

קנאביס קנביס רפואי מריחואנה יצוא

Israeli Cannabis Company Signs Deal With Unnamed Canadian Company Worth “Hundreds of Millions of Shekels”

Together Pharma announced the deal days before Israel’s cannabis export reform was blocked yet again by a ministerial dispute

אינטק פארמה ממנה את ד"ר ג'ון קוזריץ' לתפקיד יו"ר החברה

Intec Pharma Announces Public Offering of Ordinary Shares on Nasdaq

11.04.18|Dror Reich

The pharmaceutical company is currently listed on Nasdaq and the Tel Aviv Stock Exchange. Investment firm Oppenheimer & Co.will serve as the sole book-running manager

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich

Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners

הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich

The facility in Ashdod is one of five Teva intends to sell or close in its home country

יו"ר ועד עובדי טבע כפר סבא אלירן קוזליק

In Protest of New Bonus Plan, Teva Sued by Israeli Employees

15.03.18|Dror Reich

After announcing the cancellation of its annual bonuses for 2017 due to debt, the Israel-based drugmaker rolled out a performance-based bonus scheme for 2018 in February

מנכ"ל טבע החדש קור שולץ 2

Teva Increases Junk Senior Note Offering to $4.5 Billion

08.03.18|Lilach Baumer

Last week the debt-laden drugmaker announced a $3.5 billion-equivalent offering to repay its short-term $1.5 billion outstanding debt due July

תרופות טבע גלולות תרופה

Teva to Repay Due Loans with Junk Bond Private Offering

01.03.18|Lilach Baumer

The debt-laden generic drugmaker is offering around $3.5 billion in senior notes in both dollar and euro denominations

מנכ"ל טבע החדש קור שולץ 2

Teva Shut Down New York, Washington Offices, Says CEO

23.02.18|Dror Reich

In a meeting with investors in Israel, CEO Kåre Schultz said the Washington offices were used mainly by lobbyists, for which Teva has no further need

אורי טל טנא פרשן שוק ההון

Teva No Longer Provides Timeline for Recovery

21.02.18|Uri Tal-Tenne

In 2017, the company said it expected moderate growth in operating profits in the U.S. in 2020

מנכ"ל טבע החדש קור שולץ

Teva Turns to Meritocracy as Part of Turnaround Plan

18.02.18|Dror Reich

A new policy the company is rolling out would see Teva employees compensated according to key performance indicators

Previous Articles More Articles